Innoviva Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
18.61
0.05
(0.27%)
Volume:
546,053
52 week range:
15.20 - 21.28
Market Cap:
1.168B
Company Description:
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma.